On 29 January, Elon Musk announced that the first human patient had received an implant from Neuralink, the billionaire’s brain-chip start-up which promises neuron-spike detection (“spikes” refer to the activity by neurons that use electrical and chemical signals to send information around the brain and to the body). The US Food and Drug Administration cleared the company to conduct implant trials on humans last year, justifying its decision on the basis that the technology may help patients overcome paralysis and other neurological conditions.
But more is at stake with respect to implantable brain-computer interfaces (BCIs) and the radical changes to our way of life their existence implies.
Subscribe to The New Statesman today from only £8.99 per month
Content from our partners
